Ignite Creation Date:
2024-05-06 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04714086
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2023-09-25
First Post:
2021-01-14
Brief Title:
Expanded Access Program for Avapritinib
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Organization Data
Organization:
Blueprint Medicines Corporation
Class:
INDUSTRY
Study ID:
BLU-285-PTA-Solid Tumors
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Blueprint Medicines Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None